A new study examined the effectiveness of pneumococcal polysaccharide conjugate vaccines in preventing different forms of community-acquired pneumonia in adults over 65 years old.
Older adults are at a higher risk for infections, including influenza. Researchers assessed whether older adults could tolerate an MF59-adjuvanted influenza vaccine and whether the vaccine boosted immune...
A new literature review aimed to update the information regarding the immunogenicity, duration of protection, effectiveness, and safety of rubella-containing vaccines.
It is well known that patients with inflammatory bowel disease are at an increased risk of infection due to the use of immunosuppressant agents. To better understand the risk for pneumococcal disease in...
Researchers recently analyzed data from the 2013-2016 National Health and Nutrition Examination Survey to determine the prevalence and incidence rates of HPV infections in the United States.
To better understand completion rates of the recombinant zoster vaccine, researchers evaluated individuals who received the first dose and tracked who received the second dose, as well as the factors...
